177 related articles for article (PubMed ID: 36559193)
1. Suppressing of Src-Hic-5-JNK-AKT Signaling Reduced GAPDH Expression for Preventing the Progression of HuCCT1 Cholangiocarcinoma.
Wu WS; Chen RF; Cheng CC; Wei JL; Lin CF; You RI; Chen YC; Lee MC; Chen YC
Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559193
[TBL] [Abstract][Full Text] [Related]
2. Targeting Src-Hic-5 Signal Cascade for Preventing Migration of Cholangiocarcinoma Cell HuCCT1.
Wu WS; Ling CH; Lee MC; Cheng CC; Chen RF; Lin CF; You RI; Chen YC
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625759
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen peroxide inducible clone-5 mediates reactive oxygen species signaling for hepatocellular carcinoma progression.
Wu JR; Hu CT; You RI; Pan SM; Cheng CC; Lee MC; Wu CC; Chang YJ; Lin SC; Chen CS; Lin TY; Wu WS
Oncotarget; 2015 Oct; 6(32):32526-44. PubMed ID: 26416447
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin inhibits growth of cholangiocarcinoma cells.
Okada T; Sawada T; Kubota K
Hepatogastroenterology; 2009; 56(89):6-10. PubMed ID: 19453019
[TBL] [Abstract][Full Text] [Related]
5. The role of hydrogen peroxide-inducible clone-5 in tumor progression.
Wu WS
Ci Ji Yi Xue Za Zhi; 2020; 32(1):1-4. PubMed ID: 32110512
[TBL] [Abstract][Full Text] [Related]
6. Influence of mTOR-inhibitors and mycophenolic acid on human cholangiocellular carcinoma and cancer associated fibroblasts.
Heits N; Heinze T; Bernsmeier A; Kerber J; Hauser C; Becker T; Kalthoff H; Egberts JH; Braun F
BMC Cancer; 2016 May; 16():322. PubMed ID: 27206490
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen peroxide inducible clone-5 sustains NADPH oxidase-dependent reactive oxygen species-c-jun N-terminal kinase signaling in hepatocellular carcinoma.
Wu JR; You RI; Hu CT; Cheng CC; Rudy R; Wu WS
Oncogenesis; 2019 Aug; 8(8):40. PubMed ID: 31387985
[TBL] [Abstract][Full Text] [Related]
8. Taurocholate Induces Cyclooxygenase-2 Expression via the Sphingosine 1-phosphate Receptor 2 in a Human Cholangiocarcinoma Cell Line.
Liu R; Li X; Qiang X; Luo L; Hylemon PB; Jiang Z; Zhang L; Zhou H
J Biol Chem; 2015 Dec; 290(52):30988-1002. PubMed ID: 26518876
[TBL] [Abstract][Full Text] [Related]
9. Anti-metastatic Potential of Natural Triterpenoid Cucurbitacin B Against Cholangiocarcinoma Cells by Targeting Src Protein.
Kaewmeesri P; Pocasap P; Kukongviriyapan V; Prawan A; Kongpetch S; Senggunprai L
Integr Cancer Ther; 2022; 21():15347354221124861. PubMed ID: 36154723
[TBL] [Abstract][Full Text] [Related]
10. Regulation of contractility by Hsp27 and Hic-5 in rat mesenteric small arteries.
Srinivasan R; Forman S; Quinlan RA; Ohanian J; Ohanian V
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H961-9. PubMed ID: 18083901
[TBL] [Abstract][Full Text] [Related]
11. Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines.
Yang J; Sontag D; Gong Y; Minuk GY
Ann Hepatol; 2021; 21():100265. PubMed ID: 33045415
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
13. Metformin Inhibits Migration and Invasion of Cholangiocarcinoma Cells.
Trinh SX; Nguyen HT; Saimuang K; Prachayasittikul V; Chan On W
Asian Pac J Cancer Prev; 2017 Feb; 18(2):473-477. PubMed ID: 28345832
[TBL] [Abstract][Full Text] [Related]
14. Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway.
Indramanee S; Sawanyawisuth K; Silsirivanit A; Dana P; Phoomak C; Kariya R; Klinhom-On N; Sorin S; Wongkham C; Okada S; Wongkham S
Sci Rep; 2019 Nov; 9(1):17266. PubMed ID: 31754244
[TBL] [Abstract][Full Text] [Related]
15. MiR-376c down-regulation accelerates EGF-dependent migration by targeting GRB2 in the HuCCT1 human intrahepatic cholangiocarcinoma cell line.
Iwaki J; Kikuchi K; Mizuguchi Y; Kawahigashi Y; Yoshida H; Uchida E; Takizawa T
PLoS One; 2013; 8(7):e69496. PubMed ID: 23922722
[TBL] [Abstract][Full Text] [Related]
16. Preclinical trial of targeting the Hic-5-mediated pathway to prevent the progression of hepatocellular carcinoma.
Wu WS; Cheng CC; Lee YH; Wei JL; Chen RF; Lin CF; You RI; Chen YC; Shih HM; Hu CT; Chang HH; Lee MC; Chen YC
Am J Cancer Res; 2023; 13(10):4903-4917. PubMed ID: 37970347
[TBL] [Abstract][Full Text] [Related]
17. Atractylodin inhibited the migration and induced autophagy in cholangiocarcinoma cells via PI3K/AKT/mTOR and p38MAPK signalling pathways.
Acharya B; Chaijaroenkul W; Na-Bangchang K
J Pharm Pharmacol; 2021 Aug; 73(9):1191-1200. PubMed ID: 33885818
[TBL] [Abstract][Full Text] [Related]
18. Clonorchis sinensis excretory-secretory products increase malignant characteristics of cholangiocarcinoma cells in three-dimensional co-culture with biliary ductal plates.
Won J; Cho Y; Lee D; Jeon BY; Ju JW; Chung S; Pak JH
PLoS Pathog; 2019 May; 15(5):e1007818. PubMed ID: 31121000
[TBL] [Abstract][Full Text] [Related]
19. The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma.
Correnti M; Cappon A; Pastore M; Piombanti B; Lori G; Oliveira DVPN; Munoz-Garrido P; Lewinska M; Andersen JB; Coulouarn C; Sulpice L; Peraldo Neia C; Cavalloni G; Quarta S; Biasiolo A; Fassan M; Ramazzotti M; Parri M; Recalcati S; di Tommaso L; Campani C; Invernizzi P; Torzilli G; Marra F; Pontisso P; Raggi C
Liver Int; 2022 Jan; 42(1):233-248. PubMed ID: 34478594
[TBL] [Abstract][Full Text] [Related]
20. CD147 augmented monocarboxylate transporter-1/4 expression through modulation of the Akt-FoxO3-NF-κB pathway promotes cholangiocarcinoma migration and invasion.
Dana P; Saisomboon S; Kariya R; Okada S; Obchoei S; Sawanyawisuth K; Wongkham C; Pairojkul C; Wongkham S; Vaeteewoottacharn K
Cell Oncol (Dordr); 2020 Apr; 43(2):211-222. PubMed ID: 31729681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
